|
|
|
|
|
Session 16
Oral Abstract Presentations HIV Replication: Integration and Regulation Session Day and Time: Wednesday 10 - 11:30 am Presentation Time: 10:45 Room: Ballroom A |
Background: HIV-1 replication in primary human T-cells and
monocytes requires VIF. VIF is required in these cells to overcome the
inhibitory activity of the cellular protein ABOBEC-3G/CEM15, a protein that
belongs to a family of RNA editing enzymes. The mechanism by which APOBEC3G
interferes with HIV-1 replication is not understood. To begin to get insight
into its function, we identified and characterized the murine homologue of
APOBEC3G and tested its ability to inhibit HIV-1 replication and for VIF to act
on it.
Methods: cDNAs corresponding to murine homologues of human
APOBEC3G were amplified by RT-PCR from murine lymphoid organs and rodent cell
lines. The cDNAs were cloned into an expression vector and expressed with an
epitope tag in transfected cells. The VIF co-factor activity of the protein was
measured using a rapid VIF activity assay in which virion infectivity was
monitored with a LTR-Luciferase reporter cell line. Real-time Q-PCR of newly
infected cells was used to determine the step at which co-factor activity is
manifested. Northern and real-time Q-PCR analysis were used to characterize the
cell-type expression of the murine homologues.
Results: Murine APOBEC3G/CEM15 was a potent inhibitor of HIV-1
virion infectivity. Interestingly, it was more potent than the human protein. As
little as 1 ng of the murine cofactor cDNA vector effectively blocked HIV-1
infectivity. Moreover, HIV-1 VIF was unable to reverse the inhibitory activity
of the murine cofactor unless it was expressed at a very low level. Expression
of the gene in the animal was restricted to lymphoid tissues including spleen,
thymus, and lymph nodes, and in addition, heart and lung. Real-time PCR
analysis of newly infected cells showed that the mouse co-factor acted to block
the initiation of reverse transcription. APOBEC3G derived from Chinese hamster
or rat did not have inhibitory activity on HIV-1 virion infectivity. Interestingly,
murine APOBEC3G was able to partially block HIV-1 replication in target cells,
a finding that is at odds with the activity of the human homologue.
Conclusions: Murine APOBEC3G is a potent inhibitor of
HIV-1 replication and is largely independent of VIF. This protein may play a
role in determining the species specificity of HIV-1 replication in mouse and
other species. In addition, the findings separate 2 functions of APOBEC3G, one
that inhibits virion infectivity and one that is targeted by VIF.